Papillary thyroid carcinoma (PTC) in Lynch syndrome: Report of two cases and discussion on Lynch syndrome behaviour and genetics.

[1]  Kieran Sheahan,et al.  Lynch Syndrome: An Updated Review , 2014, Genes.

[2]  Alexander M. Metcalf,et al.  Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  Rodney J Scott,et al.  Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database , 2013, Nature Genetics.

[4]  C. Boland,et al.  The History of Lynch Syndrome , 2013, Familial Cancer.

[5]  P. Møller,et al.  Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts , 2013, Gut.

[6]  C. Boland,et al.  Lynch Syndrome-Associated Extracolonic Tumors Are Rare in Two Extended Families With the Same EPCAM Deletion , 2011, The American Journal of Gastroenterology.

[7]  D. Maglott,et al.  Deciphering the colon cancer genes—report of the InSiGHT‐Human Variome Project Workshop, UNESCO, Paris 2010 , 2011, Human mutation.

[8]  C. Boland,et al.  Report from the Jerusalem workshop on Lynch syndrome-hereditary nonpolyposis colorectal cancer. , 2010, Gastroenterology.

[9]  J. Reid,et al.  Analysis of PTEN, BRAF, and EGFR status in determining benefit from cetuximab therapy in wild-type KRAS metastatic colon cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  Heather Hampel,et al.  Feasibility of screening for Lynch syndrome among patients with colorectal cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  J. Potter,et al.  The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. , 2008, Gastroenterology.

[12]  A. Karrenbeld,et al.  Thyroid cancer in a patient with a germline MSH2 mutation. Case report and review of the Lynch syndrome expanding tumour spectrum , 2008, Hereditary cancer in clinical practice.

[13]  C. Boland,et al.  Who should be sent for genetic testing in hereditary colorectal cancer syndromes? , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  F. Cetta,et al.  Germ-line and Somatic Mutations of the APC Gene and/or ß Catenin Gene in the Occurrence of FAP Associated Thyroid Carcinoma , 2007, World Journal of Surgery.

[15]  J. Jass.  Classification of colorectal cancer based on correlation of clinical, morphological and molecular features , 2007, Histopathology.

[16]  Harry Campbell,et al.  Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. , 2006, The New England journal of medicine.

[17]  W. Frankel,et al.  Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). , 2005, The New England journal of medicine.

[18]  J. Potter,et al.  Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. , 2005, JAMA.

[19]  R. Broaddus,et al.  Unusual tumors associated with the hereditary nonpolyposis colorectal cancer syndrome , 2004, Modern Pathology.

[20]  P. Møller,et al.  Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance. , 2004, Gastroenterology.

[21]  Sudhir Srivastava,et al.  Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. , 2004, Journal of the National Cancer Institute.

[22]  Daniel J Sargent,et al.  Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  P. Møller,et al.  MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  M. Pelizzo,et al.  Genetics and clinicopathological findings in thyroid carcinomas associated with familial adenomatous polyposis. , 1999, The American journal of pathology.

[25]  H T Lynch,et al.  New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. , 1999, Gastroenterology.

[26]  A. Fusco,et al.  Genetic Alterations in Thyroid Carcinoma Associated with Familial Adenomatous Polyposis: Clinical Implications and Suggestions for Early Detection , 1998, World Journal of Surgery.

[27]  S Srivastava,et al.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. , 1998, Cancer research.

[28]  H. Lynch,et al.  Colorectal and extracolonic cancer variations in MLH1/MSH2 hereditary nonpolyposis colorectal cancer kindreds and the general population , 1998, Diseases of the colon and rectum.

[29]  C. Boland,et al.  A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. , 1997, Journal of the National Cancer Institute.

[30]  R. Kolodner,et al.  Identification of mismatch repair genes and their role in the development of cancer. , 1995, Current opinion in genetics & development.

[31]  Darryl Shibata,et al.  Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis , 1993, Nature.

[32]  K. Kinzler,et al.  Clues to the pathogenesis of familial colorectal cancer. , 1993, Science.

[33]  S N Thibodeau,et al.  Microsatellite instability in cancer of the proximal colon. , 1993, Science.

[34]  J. Mecklin,et al.  The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC) , 1991, Diseases of the colon and rectum.

[35]  R. Elston,et al.  Hereditary nonpolyposis colorectal cancer (lynch syndromes I and II). I. Clinical description of resource , 1985, Cancer.

[36]  R. Elston,et al.  Hereditary nonpolyposis colorectal cancer (lynch syndromes I and II). II. Biomarker studies , 1985, Cancer.

[37]  F. Troncale,et al.  Familial colonic cancer without antecedent polyposis. , 1984, Annals of internal medicine.

[38]  C. Boland.  Cancer family syndrome , 1978, The American Journal of Digestive Diseases.

[39]  H. Lynch,et al.  Cancer family “G” revisited: 1895‐1970 , 1971, Cancer.

[40]  V. Glidzić,et al.  [Hereditary nature of cancers of the colon]. , 1968, Bulletin du cancer.

[41]  M. Kartagener,et al.  [Familial incidence of double malignancies]. , 1966, Schweizerische medizinische Wochenschrift.

[42]  S. Nilsson,et al.  FAMILIAL DISPOSITION OF CANCER OF THE GASTROINTESTINAL TRACT. , 1965, Acta chirurgica Scandinavica.

[43]  U. Heim,et al.  [DOUBLE CANCER IN SIBLINGS. FAMILIAL ASSOCIATION OF CANCER OF THE GENITALIA AND INTESTINES]. , 1965, Swiss medical weekly.

[44]  F. Heinzelmann.  [ON A CANCER FAMILY. A CONTRIBUTION TO THE PROBLEM OF THE HEREDITARY ASPECTS OF COLONIC CARCINOMA]. , 1964, Helvetica chirurgica acta.

[45]  T. Kluge.  FAMILIAL CANCER OF THE COLON. , 1964, Acta chirurgica Scandinavica.

[46]  D. Savage.  A Family History of Uterine and Gastro-intestinal Cancer , 1956 .

[47]  A. S. Warthin.  HEREDITY WITH REFERENCE TO CARCINOMA: AS SHOWN BY THE STUDY OF THE CASES EXAMINED IN THE PATHOLOGICAL LABORATORY OF THE UNIVERSITY OF MICHIGAN, 1895-1913 , 1913 .

[48]  Julie O. Culver,et al.  Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study. , 2011, The Lancet. Oncology.

[49]  E. Urso,et al.  A ten markers panel provides a more accurate and complete microsatellite instability analysis in mismatch repair-deficient colorectal tumors. , 2010, Cancer biomarkers : section A of Disease markers.

[50]  Suet Yi Leung,et al.  Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1 , 2009, Nature Genetics.

[51]  R. Houlston,et al.  Chromosome 8q23.3 and 11q23.1 variants modify colorectal cancer risk in Lynch syndrome. , 2009, Gastroenterology.

[52]  Jeffrey R. Botkin,et al.  Summary of Recommendations: The Evaluation of Genomic Applications , 2022 .

[53]  F. Cetta,et al.  Germ-line and somatic mutations of the APC gene and/or b catenin gene in the occurrence of FAP associated thyroid carcinoma. Author's reply , 2007 .

[54]  S. Olschwang,et al.  Germline mutations of the APC gene in patients with familial adenomatous polyposis-associated thyroid carcinoma: results from a European cooperative study. , 2000, The Journal of clinical endocrinology and metabolism.

[55]  J. Knezetic,et al.  A century of progress in hereditary nonpolyposis colorectal cancer (lynch syndrome) , 1999, Diseases of the colon and rectum.

[56]  J. A. Bargen,et al.  FAMILIAL TRENDS IN HUMAN CANCER , 1941 .